• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic responds to NY Times story about failed ventilator contract

Medtronic responds to NY Times story about failed ventilator contract

March 30, 2020 By Sean Whooley

Medtronic logo updatedMedtronic (NYSE:MDT) is providing additional facts in response to a New York Times report detailing an acquisition by Covidien that allegedly changed the course of a government contract designed to increase ventilator supply, now a major problem amid the coronavirus pandemic.

Medtronic bought Covidien for $50 billion in 2015 — years after the events described in the Times article.

The Times article, headlined “The U.S. Tried to Build a New Fleet of Ventilators. The Mission Failed,” ran online on March 29 and detailed Covidien’s $108 million purchase of Newport Medical in 2012. Newport Medical was a small California-based company that previously agreed to a $6.1 million upfront deal in 2009 with the expectation of further payment from the government as it continued to add ventilators to the national stockpile.

According to the report, the plan was for Newport to file for market approval for the ventilators in September 2013, but Covidien after acquiring Newport asked for more funding and assigned Newport executives to new roles away from the project.

By 2014, there were no ventilators delivered to the government, and the government canceled the contract after Covidien expressed its desire to be free from it, according to the Times report.

Medtronic claims that the article lacked important information regarding Newport’s contract with the government.

Medtronic’s statement outlined that after Covidien became aware of Newport’s contract with the government, it learned that the company’s work on the ventilator design had “significant gaps” between the promises made to the government and what the company was capable of delivering, on both the cost of production and product performance fronts. That, according to Medtronic, made Covidien question Newport’s ability to complete the project as agreed.

Covidien was unable to address the gaps it saw and recognized that it could not deliver the product close to the target cost required by the contract. On top of that, the ventilator did not win FDA approval for use in neonatal populations, which was required in the contract, according to Medtronic’s statement.

Fridley, Minn.–based Medtronic added that its present efforts with regards to coronavirus include the increase of ventilator production by more than 40% and 24/7 shifts to produce as many as possible. The company said it is also working with third parties to explore other non-traditional mechanisms to increase ventilator production.

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Food & Drug Administration (FDA), Mergers & Acquisitions, Regulatory/Compliance, Respiratory Tagged With: coronavirus, COVID-19, Covidien, FDA, Medtronic, Newport Medical Instruments

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy